TB Research

A class of hydrazones are active against non-replicating Mycobacterium tuberculosis

Bonnett SA, Dennison D, Files M, Bajpai A, Parish T

PloS one · 2018-10

Abstract

There is an urgent need for the development of shorter, simpler and more tolerable drugs to treat antibiotic tolerant populations of Mycobacterium tuberculosis. We previously identified a series of hydrazones active against M. tuberculosis. We selected five representative compounds for further analysis. All compounds were active against non-replicating M. tuberculosis, with two compounds demonstrating greater activity under hypoxic conditions than aerobic culture. Compounds had bactericidal activity with MBC/MIC of < 4 and demonstrated an inoculum-dependent effect against aerobically replicating bacteria. Bacterial kill kinetics demonstrated a faster rate of kill against non-replicating bacilli generated by nutrient starvation. Compounds had limited activity against other bacterial species. In conclusion, we have demonstrated that hydrazones have some attractive properties in terms of their anti-tubercular activity.

MeSH terms

  • Humans
  • Mycobacterium tuberculosis
  • Tuberculosis
  • Oxygen
  • Hydrazones
  • Antitubercular Agents
  • Microbial Sensitivity Tests
  • Microbial Viability